The purpose of the study is to: – Establish and evaluate a system for collection of filgrastim-mobilized peripheral blood stem cells from National Marrow Donor Program donors (NMDP) donors – Assess the safety among NMDP donors of filgrastim administration and PBSC leukapheresis – Assess the safety and efficacy of filgrastim-mobilized PBSC in unrelated donor hematopoietic stem cell transplant recipients – Determine the acceptability of stem cell donation by filgrastim stimulated apheresis in normal donors